🇺🇸 FDA
Pipeline program

AMT-676

AMT-676-01

Phase 1 small_molecule active

Quick answer

AMT-676 for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Multitude Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Multitude Therapeutics
Indication
Advanced Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials